These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4740900)

  • 21. Adrenergic regulation of insulin secretion during fasting in normal subjects.
    Misbin RI; Edgar PJ; Lockwood DH
    Diabetes; 1970 Oct; 19(10):688-93. PubMed ID: 4394414
    [No Abstract]   [Full Text] [Related]  

  • 22. [Insulin secretion after administration of sulfonylurea in normal and diabetic subjects].
    Okajima J
    Nihon Naibunpi Gakkai Zasshi; 1974 Jan; 50(1):19-29. PubMed ID: 4210027
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.
    Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG
    Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the role of the adrenergic substrate in the regulation of the hypothalamus of the blood coagulation system].
    Markosian AA; Chepurov AK
    Fiziol Zh SSSR Im I M Sechenova; 1967 Dec; 53(12):1455-62. PubMed ID: 5615343
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of a rapid intravenous injection of glucose or tolbutamide on plasma-insulin concentration in normal and diabetic subjects.
    Schreuder HB; Schopman W
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):523. PubMed ID: 5582727
    [No Abstract]   [Full Text] [Related]  

  • 26. The general and local metabolic response to acute myocardial infarction.
    Opie LH
    Acta Biol Med Ger; 1972; 28(6):873-92. PubMed ID: 4564942
    [No Abstract]   [Full Text] [Related]  

  • 27. [The influence of age on the relations between the glycide and fat metabolism].
    Páv J
    Sb Lek; 1968 May; 70(5):148-55. PubMed ID: 4871294
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of glucose, insulin, and lipid metabolism in amyotrophic lateral sclerosis and other neuromuscular disorders.
    Mueller PS; Quick DT
    J Lab Clin Med; 1970 Aug; 76(2):190-201. PubMed ID: 5434000
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
    Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
    Verh Dtsch Ges Inn Med; 1971; 77():556-9. PubMed ID: 5155896
    [No Abstract]   [Full Text] [Related]  

  • 30. [Somatotropin secretion stimulation test for diencephalic and pituitary diseases, with special reference to the tests using arginine and insulin].
    Nakagawa K; Okamoto M; Horiuchi Y; Mashimo K
    Saishin Igaku; 1969 Nov; 24(11):2333-9. PubMed ID: 5359819
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum growth hormone, serum immunoreactive insulin and blood glucose response to intravenous tolbutamide in postmenopausal women with and without natural oestrogen therapy.
    Syvälahti E; Erkkola R; Punnonen R; Rauramo L
    Acta Pharmacol Toxicol (Copenh); 1976 Mar; 38(3):177-85. PubMed ID: 988954
    [No Abstract]   [Full Text] [Related]  

  • 32. [Obesity and diabetes. II. Tolbutamide intravenous test in obese patients].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1970 May; 31(2):88-99. PubMed ID: 5470191
    [No Abstract]   [Full Text] [Related]  

  • 33. Carbohydrate metabolism in patients with primary hepatocellular carcinoma.
    Vinik AI; Pooler W
    Clin Sci Mol Med; 1973 Sep; 45(3):387-96. PubMed ID: 4361808
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibition of the insulo-pancreatic response to intravenous glucose and tolbutamide administration during infusion of epinephrine].
    Laudicina E; Bompiani G; Angileri G; Mancuso L
    Folia Endocrinol; 1967 Apr; 20(2):154-63. PubMed ID: 4864821
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of propranolol on HGH secretion after endovenous tolbutamide load in obese subjects.
    Carducci Artenisio A; Sprovieri M; Albanese MC; Allegra V; Ragonese F; Corsi V
    Horm Metab Res; 1973 Nov; 5(6):473-4. PubMed ID: 4767004
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the plasmatic concentration of non-esterified fatty acids during the intravenous tolbutamide test in the aged].
    Locatelli GR; Piotti LE
    G Gerontol; 1966 Oct; 14(10):961-8. PubMed ID: 5993793
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of leptin administration in non-obese human subjects.
    Mackintosh RM; Hirsch J
    Obes Res; 2001 Aug; 9(8):462-9. PubMed ID: 11500526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic studies in diabetics on tolbutamide. Comparison of a single dose with a divided dose regimen.
    Vinik AI; Jackson WP; Keller P; Marine N
    Diabetologia; 1968 Aug; 4(4):203-9. PubMed ID: 5738360
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the influence of catecholamines on the turnover rate of free fatty acids and the formation of plasma triglycerides].
    Sandhofer F; Sailer S; Dienstl F; Braunsteiner H
    Klin Wochenschr; 1967 May; 45(9):486-92. PubMed ID: 5585807
    [No Abstract]   [Full Text] [Related]  

  • 40. [S.N.V. and insulin secretion. 3. Restorative effect of aminophylline a phosphodiesterase inhibitor, on catecholamine inhibition of insulin secretion].
    Carducci Artenisio A; Albanese MC; Allegra V; Alibrando S; Corsi V
    Boll Soc Ital Biol Sper; 1973 Jul; 49(14):883-8. PubMed ID: 4367177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.